Podcasts about Johns Hopkins

The medical system expects you to chase 33 different screening appointments across multiple specialists and check your organs one at a time. But there's a smarter way that scans your entire body in under an hour to catch cancer, aneurysms, fatty liver, and other serious health issues before they become life-threatening. In today's episode, I sit down with Dr. Daniel Durand, Chief Medical Officer of Prenuvo, to talk about the real-world power (and limitations) of proactive whole-body MRI screening. Dr. Durand walks us through how this advanced screening method detects over 500 conditions, many of which traditional screenings miss. We talk about the importance of early detection for cancers and neurodegenerative diseases, and how this proactive approach to health can save lives.   "It's better to see things early when you can intervene, and see them in a controlled context when you're healthy." ~ Dr. Daniel Durand   In This Episode: -  Introduction to Dr. Daniel Durand and his background - Conventional vs whole body scans - Conditions that whole-body MRI can detect - Bringing scans to underserved populations - Imaging for risk identification vs. diagnosis - How often you should rescan and what to expect - EMF exposure concerns and MRI safety parameters - How consumer demand is driving change in medicine   Products & Resources Mentioned: Prenuvo Whole-Body MRI: My listeners get a special discount when you book at https://prenuvo.com/wendymyers  Bon Charge Blue Light Blockers: Get 15% off with code WENDY at https://boncharge.com  Organifi Happy Drops: Save 20% with code MYERSDETOX at https://organifi.com/myersdetox  Organifi Collagen: Use code MYERSDETOX for 20% off at https://organifi.com/myersdetox  Chef's Foundry P600 Ceramic Cookware: Get 20% off with code WENDY20 at https://chefsfoundry.com  Heavy Metals Quiz: Take it for free at https://heavymetalsquiz.com    About Dr. Daniel Durand: Dr. Daniel Durand is a dual board-certified adult & pediatric radiologist and Chief Medical Officer at Prenuvo, where he leads clinical operations, research, and the medical group for the world's largest network of proactive whole-body MRI clinics. Previously, he served as Chief Clinical Officer & Chief Innovation Officer at LifeBridge Health and held leadership roles in accountable care at Johns Hopkins. He is passionate about empowering primary care and shifting medicine toward true prevention through advanced imaging. Learn more at: https://prenuvo.com/wendymyers    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello are bewildered and dismayed by RFK Jr's announced changes in the routine childhood immunization schedule, though not unpredicted, and highlight the science and evidence which eviscerate these changes, then deep dives into recent statistics on the measles epidemic- in particular in South Carolina, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, estimated societal burden of COVID-19 illness, deaths and hospitalizations, benefit of maternal COVID-19 vaccination, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, neurodevelopmental consequences of in-utero SARS-CoV-2 infection and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode 7 great Danish cheeses you should know (Cheese Professor) Norovirus in on the rise! (WasterWater Scan) Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis (JAMA Open) TUESDAY MEASLES UPDATE: DPH Reports 124 New Measles Cases in Upstate, New Public Exposures, and Upcoming Vaccination Opportunities (South Carolina: Department of Public Health-they have one?) Measles cases soar in South Carolina, top 400 (CIDRAP) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) North Dakota confirms pediatric flu deaths as some states note surge in flu activity (CIDRAP) OPTION 2: XOFLUZA $50 Cash Pay Option (Xofluza) The Best Flu Drug Americans Aren't Taking (The Atlantic) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study (Lancet: Infectious Diseases) Interim Safety of RSVpreF Vaccination During Pregnancy (JAMA) Pfizer's RSV vaccine safe to use during pregnancy, study suggests (CIDRAP) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Evaluating the Effectiveness of 2024–2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study (Infectious Diseases and Therapy) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis(Scientific Reports) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Incidence and Severity of Postacute Sequelae of SARS-CoV-2 Infection in the Omicron Era: A Prospective Cohort Study (JID) Reaching out to US house representative Letters read on TWiV 1288 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

NASA's SpaceX Crew-11 has returned to Earth, concluding a more than five-month mission aboard the International Space Station (ISS). Slingshot Aerospace has been awarded a $27 million US Space Force (USSF) contract to modernize scenario training activities. Chinese commercial company CAS Space debuted its suborbital two-stage research rocket, and more. Remember to leave us a 5-star rating and review in your favorite podcast app. Be sure to follow T-Minus on LinkedIn and Instagram. T-Minus Guest Our guest today is Cherie Matthew, Architect/ Project Manager at Jacobs.  You can connect with Cherie on LinkedIn, and learn more about Jacobs on their website. Selected Reading NASA's SpaceX Crew-11 Mission Returns, Splashes Down off California Slingshot Aerospace Awarded $27 Million Space Force Contract to Power the AI-Driven Training Environment for Space Warfare CAS Space Debuts Suborbital Research and Technology Testing Rocket Axelspace Signs MoU with Ethiopian Company to Address Social Challenges through the Utilization of Satellite Data Space Force Teams with Universities to Advance Sonic Boom Research in California NASA and Johns Hopkins play the cult video game DOOM on satellites Share your feedback. What do you think about T-Minus Space Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show.  Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at space@n2k.com to request more info. Want to join us for an interview? Please send your pitch to space-editor@n2k.com and include your name, affiliation, and topic proposal. T-Minus is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Don Watenpaugh is a scientist, sleep clinician, data artist, and poet with a PhD in physiology. His extensive career spans academia, NASA, and the U.S. Navy, focusing on human sleep, exercise, and environmental physiology. As a board-certified sleep medicine specialist, he directed a large urban sleep clinic for over 13 years, caring for patients and educating healthcare providers. Dr. Watenpaugh is an adjunct faculty member in physiology, anatomy, and biomedical engineering. He now creates data-driven art and poetry at Studio Videnda. In this episode, he brings his deep expertise to the critical relationship between sleep and concussion recovery.Episode Summary:In this episode of the Concussion Coach Podcast, host Bethany Lewis welcomes sleep expert Dr. Don Watenpaugh, to explore the complex connection between sleep disturbances and concussion recovery. Dr. Watenpaugh explains the physiological reasons why concussions commonly disrupt sleep—from brain inflammation impacting cerebral spinal fluid "brainwashing" during non-REM sleep to the exacerbation of pre-existing conditions like PTSD, depression, and anxiety. The conversation delves into the different types of insomnia (sleep onset and maintenance) and their potential causes, including restless leg syndrome and sleep apnea.Crucially, Dr. Watenpaugh provides actionable, evidence-based strategies to improve sleep and support brain healing. He discusses the evolving role of exercise as medicine, emphasizing safe, non-jarring activities like stationary cycling. He covers practical sleep hygiene tips, such as the importance of spinal alignment during sleep, the potential benefits of slightly elevating the head of the bed, and the disruptive effects of electronics and blue light. The discussion also touches on the careful use of supplements like melatonin, the special considerations for military personnel and student-athletes, and the overarching importance of patient education and self-advocacy. This episode is packed with science-backed insights to help listeners break the vicious cycle of poor sleep and prolonged concussion symptoms.Key Resources & Strategies Mentioned:Exercise as Medicine: Safe, mild-to-moderate exercise (e.g., stationary cycling to avoid head acceleration) can aid concussion recovery and improve sleep. Always consult your doctor.Sleep Position & Environment:Maintain spinal alignment; avoid stomach sleeping to prevent neck torsion.Consider slightly elevating the head of the bed to help reduce intracranial pressure.Remove electronics (TVs, phones) from the bedroom to avoid mental stimulation and blue light, which suppresses natural melatonin.Addressing Underlying Causes:Restless Leg Syndrome (RLS): Evening exercise (ending 2+ hours before bed) can help. Other treatments are available.Sleep Apnea: A common cause of sleep maintenance insomnia. Treatment (e.g., CPAP) is critical for overall health and concussion recovery.Hormonal Factors: Post-menopausal women may see a link between hormone changes and sleep apnea onset.Melatonin & Supplements: Prioritize natural melatonin production by managing light exposure. If using supplements, start with a low dose well before bedtime, monitor for side effects like headaches or grogginess, and consult your doctor.Patient Advocacy & Reliable Research: Dr. Watenpaugh stresses the importance of educating yourself using reliable, peer-reviewed sources like PubMed/MEDLINE, reputable medical institutions (e.g., Johns Hopkins & the Mayo Clinic), and professional organizations (e.g., American Academy of Sleep Medicine).Dr. Don Watenpaugh's website:Website/Data Art Studio: https://www.studiovidenda.comBethany Lewis & The Concussion Coach:Free Guide: "5 Best Ways to Support Your Loved One Dealing with a Concussion" - Download at www.theconcussioncoach.comConcussion Coaching Program: For personalized mentorship in recovery. Sign up for a free consultation HERE

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Shai Rozen, MD, discuss the following articles from the January 2026 issue: "The Natural Progression of Synkinesis" by Rail, Bhatia, Dragun, et al. Read the article for FREE: https://bit.ly/NaturalSynk Special guest, Shai Rozen is Professor and Vice-Chairman in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center and Director of the Facial Reanimation Program, specializing in treating patients with facial paralysis. He completed both general surgery and plastic surgery training at Johns Hopkins, followed by fellowships in both craniofacial and peripheral nerve surgery.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJan26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Protests are sweeping Iran and the government is cracking down hard, fearing the uprisings pose a threat to the theocratic regime. There is an internet blackout in the country making it hard to get information. We hear a rare first-person account of the protests from a Johns Hopkins professor who visits the Iran frequently and who recently attended a protest there.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

We kicked off the program with four news stories and different guests on the stories we think you need to know about! THE POWER OF THE PAUSE: 90 Seconds to Calm, Reset, and Reconnect.Guest: Jillian Pransky – Author & mindfulness teacher & Yoga therapist 5 Ways to Use AI for a Healthier 2026. Accessible AI tools and affordable wearables can simplify healthy habits rather than overwhelm people. New Book: Better Health with AI: Simple Steps to Real ResultsGuest: Dr. Earl J. Campazzi, Jr, a Johns Hopkins–trained preventive medicine physician with 35+ years of clinical experience and four board certifications Why you should put down your phone and daydream insteadGuest: Maggie Penman – WaPo Reporter In reversal, U.S. loosens guidance on alcoholGuest: David Ovalle – WaPo Reporter that focuses on opioids and addiction See omnystudio.com/listener for privacy information.

Luke Hedrick, Dave Furfaro, and recurrent RFJC guest Robert Wharton are joined again today by Nicole Ng to discuss the FIBRONEER-IPF trial investigating Nerandomilast in patients with IPF. This trial was published in NEJM in 2025 and looked at Neradomilast vs placebo for treating patients with IPF, on or off background anti-fibrotic therapy. This agents is now FDA approved for pulmonary fibrosis, and understanding the trial results is essential for any pulmonary physician treating patients with IPF or progressive pulmonary fibrosis. Article and Reference Today’s episode discusses the FIBRONEER-IPF trial published in NEJM in 2025. Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Clerisme-Beaty E, Gordat M, Wachtlin D, Liu Y, Schlecker C, Stowasser S, Zoz DF, Wijsenbeek MS; FIBRONEER-IPF Trial Investigators. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12;392(22):2193-2202. doi: 10.1056/NEJMoa2414108. Epub 2025 May 18. PMID: 40387033. https://www.nejm.org/doi/abs/10.1056/NEJMoa2414108 Meet Our Guests Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a pulmonary and critical care fellow at Johns Hopkins. Dr. Nicole Ng is an Assistant Profess of Medicine at Mount Sinai Hospital, and is the Associate Director of the Interstitial Lung Disease Program for the Mount Sinai National Jewish Health Respiratory Institute. Infographic Key Learning Points Why this trial mattered IPF therapies remain limited: nintedanib and pirfenidone slow (but do not stop) decline and often cause GI side effects. Nerandomilast is a newer agent (a preferential PDE4B inhibitor) with antifibrotic + immunomodulatory effects. Phase 2 data (NEJM 2022) looked very promising (suggesting near-“halt” of FVC decline), so this phase 3 trial was a big test of that signal. Trial design essentials Industry-sponsored, randomized, double-blind, placebo-controlled, large multinational study (332 sites, 36 countries). Population: IPF diagnosed via guideline-aligned criteria with central imaging review and multidisciplinary diagnostic confirmation. Intervention: nerandomilast 18 mg BID, 9 mg BID, or placebo; stratified by background antifibrotic use. Primary endpoint: change in FVC at 52 weeks, analyzed with a mixed model for repeated measures. Key secondary endpoint: time to first acute exacerbation, respiratory hospitalization, or death (composite). Who was enrolled Typical IPF trial demographics: ~80% male, mean age ~70, many former smokers. Many were already on background therapy (~45% nintedanib, ~30–33% pirfenidone). Notable exclusions included significant liver disease, advanced CKD, recent major cardiovascular events, and psychiatric risk (suicidality/severe depression), reflecting class concerns seen with other PDE4 inhibitors. Efficacy: what the primary endpoint showed Nerandomilast produced a statistically significant but modest reduction in annual FVC decline vs placebo (roughly 60–70 mL difference). Importantly, it did not halt FVC decline the way the phase 2 data suggested; patients still progressed. Important nuance: interaction with pirfenidone Patients on pirfenidone had ~50% lower nerandomilast trough levels. Clinically: 9 mg BID looked ineffective with pirfenidone, so 18 mg BID is needed if used together. In those not on background therapy or on nintedanib, 9 mg and 18 mg looked similar—suggesting the apparent “dose-response” might be partly driven by the pirfenidone drug interaction Secondary and patient-centered outcomes were neutral No demonstrated benefit in the composite outcome (exacerbation/resp hospitalization/death) or its components. Quality of life measures were neutral and declined in all groups, emphasizing that slowing FVC alone may not translate into felt improvement without a disease-reversing therapy. The discussants noted this may reflect limited power/duration for these outcomes and mentioned signals from other datasets/pooling that might suggest mortality benefit—but in this specific trial, the key secondary endpoint was not positive. Safety and tolerability Diarrhea was the main adverse event: Higher overall with the 18 mg dose, and highest when combined with nintedanib (up to ~62%). Mostly mild/manageable; discontinuation due to diarrhea was relatively uncommon (but higher in those on nintedanib). Reassuringly, there was no signal for increased depression/suicidality/vasculitis despite psychiatric exclusions and theoretical class risk. How to interpret “modest FVC benefit” clinically The group framed nerandomilast as another tool that adds incremental slowing of progression. They emphasized that comparing absolute FVC differences across trials (ASCEND/INPULSIS vs this trial) is tricky because populations and “natural history” in placebo arms have changed over time (earlier diagnosis, improved supportive care, etc.). They highlighted channeling bias: patients already on antifibrotics may be sicker (longer disease duration, lower PFTs, more oxygen), complicating subgroup comparisons. Practical takeaways for real-world use All three antifibrotics are “fair game”; choice should be shared decision-making based on goals, tolerability, dosing preferences, and logistics. Reasons they favored nerandomilast in practice: No routine lab monitoring (major convenience advantage vs traditional antifibrotics). Generally better GI tolerability than nintedanib. BID dosing (vs pirfenidone TID). Approach to combination therapy: They generally favor add-on rather than immediate combination to reduce confusion about side effects—while acknowledging it may slow reaching “maximal therapy.” Dosing guidance emphasized: Start 18 mg BID for IPF, especially if combined with pirfenidone (since dose reduction may make it ineffective). 9 mg BID may be considered if dose reduction is needed and the patient is not on pirfenidone (e.g., monotherapy or with nintedanib).

414 Following Your Own Star   There comes a time in our lives where we need to stop and take stock of what we want to do next and our next steps in getting there. Perhaps it's more than just one thing, perhaps you're just floating through life trying to figure out what to do next, or perhaps you think this goal is too lofty despite all your hard work. Which is why it is so important to take all you know about others and yourself and apply it to whatever comes next. In today's episode Sarah Elkins and Professor KD Frick discuss the importance of that specific personal growth, as well as the importance of believing in others and yourself even when you aren't sure where your own star is leading you, and especially to greet the world with open arms.   Highlights Finding the right words for where you are in your life right now.  Leading with compassion and empathy. Position yourself to be able to understand.  Don't immediately dismiss someone, you never know where their combined ideas may lead. Everyone has their own North Star they follow.   Quotes "Empathy leads to approachability." "Look as long as I'm here and unless you tell me otherwise, I'm planning on reading names. Because it's the last connection students have with us."    Dear Listeners it is now your turn, What did you hear in this conversation that struck you as something that resonated? Maybe it was about not knowing what you want to do next, maybe it was I do know what I want to do next but I'm not being consistent enough to make it happen. I am so curious to hear your thoughts, please share them either in the comments or wherever you see this shared or send me an email.  And, as always, thank you for listening.    About KD KD Frick was originally trained as a health economist and began a career at Johns Hopkins as a faculty member at the Bloomberg School of Public Health; after a bit more than sixteen years in that role, with responsibilities like associate department chair and faculty senate president, a move was made to the Carey Business School as vice dean for education. The eight and one-half years spent in that role were a time of growth and expansion of opportunity. With colleagues encouraging a return to research, challenging decisions around COVID, a focus on ranking academic programs that was not of interest, and a lack of visible opportunities for advancement in administration, a decision was made to return to just a faculty role. The result has been great fulfillment, a change in teaching, and a focus on leading by teaching others to lead artisnally toward aspirational narratives for themselves and those they are developing. There is still room for work on the economics of eye care where Professor Frick has the opportunity to apply the leading with values approach that is taught in the classroom. Be sure to check out Professor Frick's LinkedIn, thoughts on tHERSday newsletter, as well as Business and Economics of Eye Care and Health!   About Sarah "Uncovering the right stories for the right audiences so executives, leaders, public speakers, and job seekers can clearly and actively demonstrate their character, values, and vision." In my work with coaching clients, I guide people to improve their communication using storytelling as the foundation of our work together. What I've realized over years of coaching and podcasting is that the majority of people don't realize the impact of the stories they share - on their internal messages, and on the people they're sharing them with. My work with leaders and people who aspire to be leaders follows a similar path to the interviews on my podcast, uncovering pivotal moments in their lives and learning how to share them to connect more authentically with others, to make their presentations and speaking more engaging, to reveal patterns that have kept them stuck or moved them forward, and to improve their relationships at work and at home. The audiobook, Your Stories Don't Define You, How You Tell Them Will is now available! Included with your purchase are two bonus tracks, songs recorded by Sarah's band, Spare Change, in her living room in Montana. Be sure to check out the Storytelling For Professionals Course as well to make sure you nail that next interview!

Dr. James Greenblatt, MD, is more than a dual board-certified psychiatrist; he is a pioneer of hope and a tireless advocate for the integration of soul and science. For over 30 years, Dr. Greenblatt has looked beyond the traditional "checklist" of symptoms to uncover the vibrant, biochemical story beneath. As the leading global expert on the clinical application of low-dose lithium and a pioneer in functional psychiatry, he has dedicated his career to a singular, transformative mission: healing the root cause so the spirit can flourish. From his academic roots at Johns Hopkins and George Washington University to his current faculty roles at Tufts and Dartmouth, Dr. Greenblatt bridges the gap between clinical excellence and compassionate, precision-based care. Through his educational platform, Psychiatry Redefined, he is shifting the global landscape of mental health—empowering a new generation of clinicians to treat the whole person rather than just the diagnosis. A prolific voice in the holistic movement, Dr. Greenblatt has authored nine life-changing books, including the bestsellers Finally Focused and Nutritional Lithium. His work invites us to reimagine what is possible for our mental well-being, moving away from temporary fixes toward a state of true, sustainable inner balance. Whether through his writing or his upcoming 2026 release, Finally Hopeful, Dr. Greenblatt continues to light the path for those seeking to reclaim their health, their clarity, and their lives.

Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: The US Food and Drug Administration's Regulation of Mifepristone Politics, Science, and the Future of FDA Drug Regulation

This week, Tee sits down with Dr. Beverly Jensen for a powerful conversation on the often-overlooked impact of electromagnetic fields (EMFs) on our health, homes, and especially our children. Dr. Beverly brings a rare blend of academic rigor, international experience, and lived wisdom. Her early career included writing on health, nutrition, and environmental education for Woman's Day, Teacher, and McGraw-Hill. She later earned her doctorate in international communication from the University of Washington and went on to build a global career spanning Egypt, the Czech Republic, and the UAE. From launching a nationally adopted noise-abatement campaign in Egypt to managing a World Bank–backed Heart Association project in the Czech Republic, Dr. Jensen has spent decades at the intersection of public health, communication, and advocacy. She also co-managed a Johns Hopkins–affiliated health promotion program in the UAE, helping shape initiatives later adopted by the Abu Dhabi Health Authority. In this episode, Tee and Dr. Jensen explore how everyday EMF exposure from cell phones to household appliances can affect daily life and childhood development. Dr. Jensen shares her personal journey into EMF awareness, practical steps families can take to reduce exposure, and why public education and legislative involvement are urgently needed. The conversation also highlights the vital role mothers play in advocating for children's long-term health. Connect with Dr.Beverly: You and EMF  Women's Medicine Bowl  Free Consultation LinkedIn Facebook YouTube Contact Your Representative Regarding House Bill 2289 National Call For Safe Technology Follow Therese "Tee" Forton-Barnes and The Green Living Gurus: Austin Air Purifiers: For podcast listeners, take 15% off any Austin Air product; please email Tee@thegreenlivinggurus.com and mention that you want to buy a product and would like the discount. See all products here: Austin Air The Green Living Gurus' Website  Instagram YouTube Facebook Healthy Living Group on Facebook Tip the podcaster! Support Tee and the endless information that she provides: Patreon Venmo: @Therese-Forton-Barnes last four digits of her cell are 8868 For further info, contact Tee: Email: Tee@thegreenlivinggurus.com Cell: 716-868-8868 DISCLAIMER: ALL INFORMATION PROVIDED HERE IS GENERAL GUIDANCE AND NOT MEANT TO BE USED FOR INDIVIDUAL TREATMENT. PLEASE CONTACT YOUR PROVIDER OR DOCTOR FOR MEDICAL ADVICE.   Produced By: Social Chameleon

This and all episodes at: https://aiandyou.net/ . What's going on with getting AI education into America's classrooms? We're finding out from Jeff Riley, former Commissioner of Education for the state of Massachusetts and founder of a new organization – Day of AI, started by MIT's Responsible AI for Social Empowerment and Education institute. And they are mounting a campaign called Responsible AI for America's Youth, which is now running across all 50 states and will run an event called America's Youth AI Festival in July 2026 in Boston. Jeff has got master's degrees from Johns Hopkins and Harvard. He was a Boston school principal and as commissioner, successfully navigated Massachusetts schools through Covid and other crises. In our conclusion, we talk about how Jeff sees the AI education of teachers evolving, responsible use of AI by students, differentiated learning, making AI in classrooms safe for teachers and students, the impact of AI on educational inequalities, the future of educational reform, and how you can get involved in AI in schools.  All this plus our usual look at today's AI headlines. Transcript and URLs referenced at HumanCusp Blog.        

Early exposure to peanut is credited with reducing the development of peanut allergy in young children, a recent study concludes, but Robert Wood, a childhood allergy expert at Johns Hopkins, says the rate of food allergies among children is increasing … What's the best strategy to avoid food allergies in young children? Elizabeth Tracey reports Read More »

Eight different cancers are increasing among those younger than fifty in the US, data since 1992 indicate. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says thyroid, colorectal and endometrial or uterine are included in that number, … Cancers increasing among those younger than fifty warrant investigation to discern causes, Elizabeth Tracey reports Read More »

Early introduction of peanut into a child's diet may help them avoid development of peanut allergy, a recent study concludes. Robert Wood, a childhood allergy expert at Johns Hopkins, says it's just not that simple when it comes to understanding … Should you feed your young child peanut to prevent allergy? Elizabeth Tracey reports Read More »

In his weekly clinical update, Dr. Griffin and Vincent Racaniello are bewildered and dismayed by RFK Jr's announced changes in the routine childhood immunization schedule, though not unpredicted, and highlight the science and evidence which eviscerate these changes, then deep dives into recent statistics on the measles epidemic- in particular in South Carolina, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, estimated societal burden of COVID-19 illness, deaths and hospitalizations, benefit of maternal COVID-19 vaccination, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, neurodevelopmental consequences of in-utero SARS-CoV-2 infection and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Childhood Immunization Schedule by Recommendation Group (US Health and Human Service) Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger (American Academy of Pediatrics) Kennedy Scales Back the Number of Vaccines Recommended for Children (NY Times) There RFK Jr. Goes Again . . .(Wall Street Journal) Hepatitis B Vaccination is an Essential Safety Net for Newborns (Johns Hopkins Bloomberg School of Public Health) Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children (JAMA Pediatrics) Rotavirus (College of Physicians of Philadelphia) Hepatitis A in the Era of Vaccination (Epidemiologic Reviews) Meningococcal Vaccination in the United States: Past, Present, And Future (Ped Drugs) Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 (CDC: MMWR) N.Y. DOH says childhood vaccine recommendations remain unchanged despite CDC's update (Spectrum 1 News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) South Carolina measles cases rise by 26 to 211, state health department says (Reuters) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024 (JAMA Internal Medicine) The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy (JAMA) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID The COVID generation: the neurodevelopmental consequences of in-utero COVID-19 exposure (Brain, behavior and Immunity) Reaching out to US house representative Letters read on TWiV 1286 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Shai Rozen, MD, discuss the following articles from the January 2026 issue: "The Efficacy of Flap Debulking after Facial Reanimation Surgery to Enhance Facial Symmetry" by Weiss, Fricke, Hohenstein, et al. Read the article for FREE: https://bit.ly/FlapDebulk Special guest, Shai Rozen is Professor and Vice-Chairman in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center and Director of the Facial Reanimation Program, specializing in treating patients with facial paralysis. He completed both general surgery and plastic surgery training at Johns Hopkins, followed by fellowships in both craniofacial and peripheral nerve surgery.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJan26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Welcome to The Chrisman Commentary, your go-to daily mortgage news podcast, where industry insights meet expert analysis. Hosted by Robbie Chrisman, this podcast delivers the latest updates on mortgage rates, capital markets, and the forces shaping the housing finance landscape. Whether you're a seasoned professional or just looking to stay informed, you'll get clear, concise breakdowns of market trends and economic shifts that impact the mortgage world.In today's episode, we look at how the residential lending space is impacting overall home affordability. Plus, Robbie sits down with Johns Hopkins' Dan Ye for a discussion on how 90 percent of human capital will be replaced in the next 10 years through AI, and how you can potentially ward off the impending doom. And we close by reviewing why rates are treading water to open 2026.

Dr. Otis Brawley of Johns Hopkins shares his insight about cancer screening, focusing on prostate cancer. Dr. Brawley explains that while prostate cancer is common and serious, evidence supporting routine PSA screening is limited and inconsistent, leading major organizations to recommend shared decision-making between doctors and patients rather than universal screening. Men of Northwestern Sub-Saharan African ancestry have higher risk, but outcomes are equal across groups when high-quality care is provided, highlighting that disparities stem mainly from access to care, not biology. He emphasizes the importance of individualized screening decisions, treatment at strong medical centers, and patient engagement, and briefly describes Johns Hopkins' MAPS peer-support program for cancer patients.

New year's greetings from PreserveCast! Today we're talking with Lori Beth Finkelstein and Michelle Fitzgerald from Johns Hopkins museums about Homewood Museum's recently opened If Homewood's Walls Could Talk: A History of an American House. Lori is the Philip Franklin Wagley Director & Curator of Johns Hopkins University's Evergreen Museum & Library and Director of Homewood Museum. Michelle is the Curator of Collections at Johns Hopkins University Museums, which is comprised of the university's two historic houses, Homewood Museum and Evergreen Museum & Library. She has curated several exhibitions at Hopkins, including the new Homewood exhibit. 

This and all episodes at: https://aiandyou.net/ . What's going on with getting AI education into America's classrooms? We're going to find out from Jeff Riley, former Commissioner of Education for the state of Massachusetts and founder of a new organization – Day of AI, started by MIT's Responsible AI for Social Empowerment and Education institute. And they are mounting a campaign called Responsible AI for America's Youth, which is now running across all 50 states and will run an event called America's Youth AI Festival in July 2026 in Boston. Jeff has got master's degrees from Johns Hopkins and Harvard. He was a Boston school principal and as commissioner, successfully navigated Massachusetts schools through Covid and other crises. We talk about what the campaign is doing and how teachers are responding to it, risks of AI and social media to kids, what to do about cheating and AI detectors, and much more! All this plus our usual look at today's AI headlines. Transcript and URLs referenced at HumanCusp Blog.        

Recording after the ball drops, Dr. Griffin and Vincent Racaniello wish everyone a Happy New Year, discuss an evidence-based approach to teaching and practice medicine and reminisce on the history of vaccine development and use before their discussion about the whooping cough outbreak of 2025 in the US and falling levels of tetanus vaccination, then Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how NY state reported the greatest number of influenza confirmed infections ever in one week during the week ending Dec 20,  where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine (JAMA) The US has seen nearly 28,000 whooping cough cases this year. Here's what you need to know (CNN) Vaccine History: Developments by Year (CHOP, Children's hospital of Philadelphia: Vaccine History) Reported Incidence of notable diseases in United States: 1952 Morbidity and Mortality Weekly Report, Vol. 1, No. 54, October 26, 1953 (CDC: Stacks) As tetanus vaccination rates decline, doctors worry about rising case numbers (nbc News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) New York State Department of Health Confirms Most Flu Cases Ever Recorded in One Week: New York State Reports 71,123 Flu Cases This Week (NY State Department of Health) Weekly surveillance report: cliff notes (CDC FluView) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns (JAMA) RSV Immunization Frequently Asked Questions(American Academy of Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1284 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Want personalized help with your application strategy? Book a free 1:1 call with one of our Former Admissions Officers here: CLICK HERE. Shannon and Titania are back—this time tackling the Johns Hopkins supplemental essay. With Hopkins celebrating its 150th anniversary, this year's prompt sounds poetic, reflective, and… a little overwhelming. But what are admissions officers actually asking for? PART 1: How to answer Every Harvard Supplemental Essay Prompts! [WATCH IT HERE] PART 2: How to answer Yale Supplemental Essay + Short Answer Prompts! [WATCH IT HERE] --- Register for our upcoming webinars. We also offer tons of free resources on our website/blog.  Questions, comments, or topic requests? Email jilian.yong@ingeniusprep.com. To learn more about InGenius Prep, visit us at ingeniusprep.com.

Calling out "Happy Christmas to all and to all a good-night,  Dr. Griffin and Vincent Racaniello discuss high path influenza in dairy herds in Wisconsin and Marburg virus in Ethiopia before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the slightly higher association of COVID-19 infection with death than following influenza infection, benefit of passive infant immunization with niresevimab, association of COVID-19 vaccine immunogenicity protection against severe disease in vulnerable populations, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, effect of remdesivir and nirmatrelvir/ritonavir on COVID-19 associated mortality, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode USDA Confirms Highly Pathogenic Avian Influenza in a Dairy Herd in Wisconsin (USDA Animal and Plant Health Inspection Service) Update: Genetic Sequencing Results for Wisconsin Dairy Herd Detection of Highly Pathogenic Avian Influenza(USDA Animal and Plant Health Inspection Service) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely(CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Increased 30-day Mortality Risk in Coronavirus Disease 2019 Compared to Seasonal Influenza (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns (JAMA) RSV Immunization Frequently Asked Questions(American Academy of Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies (Clinical Microbiology and Infection) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial (Clinical Microbiology and Infection) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments? (Nature) Reaching out to US house representative Letters read on TWiV 1282 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

It's YOUR time to #EdUp with Dr. Anthony K. Wutoh, Provost, Howard UniversityIn this episode, sponsored by the ⁠⁠⁠ELIVE 2026 Conference in Denver, Colorado, April 19-22, & the 2026 InsightsEDU Conference in Fort Lauderdale, Florida, February 17-19,YOUR cohost is Megan Dusenbery, Chief Executive Officer, KnackYOUR host is ⁠Elvin Freytes⁠How does a provost increase graduation rates by over 20% & create programs like Karsh STEM Scholars & Humanities & Social Science Scholars that send students to PhD programs at Harvard, Stanford & Johns Hopkins?What happens when an HBCU partners with Google & Amazon Studios to create Tech Exchange & Howard Entertainment programs that give students real world experience in technology & the business of entertainment?How does a university leader with 30 years of experience think about AI's transformational impact on higher education while maintaining focus on ethics, access & preparing students for the world that's coming?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Elvin Freytes⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠& ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr. Joe Sallustio⁠⁠⁠⁠⁠● Join YOUR EdUp community at ⁠The EdUp Experience⁠We make education YOUR business!P.S. Want to get early, ad-free access & exclusive leadership content to help support the show? Then ⁠⁠​subscribe today​⁠⁠ to lock in YOUR $5.99/m lifetime supporters rate! This offer ends December 31, 2025!

Today, Dave Furfaro, Luke Hedrick, and Robert Wharton discuss the PREDMETH trial published in The New England Journal of Medicine in 2025. This was a non-inferiority trial comparing prednisone to methotrexate for upfront therapy in treatment-naive sarcoidosis patients. Listen in for a break down of the trial, analysis, and clinically applicable pearls. Article and Reference Todays’ episode discusses the PREDMETH trial published in NEJM in 2025. Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, Koopman B, Loth DW, Nossent EJ, Wagenaar M, Kramer H, Wielders PLML, Bonta PI, Walen S, Bogaarts BAHA, Kerstens R, Overgaauw M, Veltkamp M, Wijsenbeek MS; PREDMETH Collaborators. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate. N Engl J Med. 2025 Jul 17;393(3):231-242. doi: 10.1056/NEJMoa2501443. Epub 2025 May 18. PMID: 40387020. https://www.nejm.org/doi/full/10.1056/NEJMoa2501443 Meet Our Hosts Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a first year pulmonary and critical care fellow at Johns Hopkins. Key Learning Points Clinical context Prednisone remains the traditional first-line treatment for pulmonary sarcoidosis when treatment is indicated, with evidence for short-term improvements in symptoms, radiographic findings, and pulmonary function—but with substantial, familiar steroid toxicities (weight gain, insomnia, HTN/DM, infection risk, etc.). Despite widespread use, glucocorticoids haven't been robustly tested head-to-head against many alternatives as initial therapy, and evidence for preventing long-term decline (especially in severe disease) is limited. Immunosuppressants (like methotrexate) are often used as steroid-sparing agents, but guideline recommendations are generally conditional/low-quality evidence, and practice varies. Why PREDMETH matters It addresses a real-world question: Can methotrexate be an initial alternative to prednisone in pulmonary sarcoidosis, rather than being reserved only for steroid-sparing later? It also probes a common clinical belief: MTX has slower onset than prednisone (often assumed, not well-proven). Trial design (what to know) Open-label, randomized, noninferiority trial across 17 hospitals in the Netherlands. Included patients with pulmonary sarcoidosis who had a clear pulmonary indication to start systemic therapy (moderate/severe symptoms plus objective risk features like reduced FVC/DLCO or documented decline, plus parenchymal abnormalities). Excluded: non–treatment-naïve patients and those whose primary indication was extrapulmonary disease. Treat-to-tolerability with escalation: both drugs started low and were slowly increased; switch/add-on allowed for inadequate efficacy or unacceptable side effects. Primary endpoint: change in FVC (with the usual caveat that FVC is “objective-ish,” but effort-dependent and not always patient-centered). Noninferiority margin: 5% FVC, justified as within biologic/measurement variation and “not clinically relevant.” Outcomes assessed at weeks 4, 16, 24; powered for ~110 patients to detect the NI margin. Patient population (who this applies to) Mostly middle-aged (~40s) with mild-to-moderate physiologic impairment on average (FVC ~77% predicted; DLCO ~70% predicted). Netherlands-based cohort with limited Black representation (~7%), which matters for generalizability. Would have been helpful to know more about comorbidities (e.g., diabetes), which can strongly influence prednisone risk. Main findings (what happened) Methotrexate was noninferior to prednisone at week 24 for FVC: Between-group difference in least-squares mean change at week 24: −1.17 percentage points (favoring prednisone) with CI −4.27 to +1.93, staying within the 5% NI margin. Timing mattered: Prednisone showed earlier benefit (notably by week 4) in FVC and across quality-of-life measures. By week 24, those early differences largely washed out—possibly because MTX “catches up,” and/or because crossover increased over time. In their reporting, MTX didn't meet noninferiority for FVC until week 24, supporting the practical message that prednisone works faster. Crossover and analysis nuance (important for interpretation) Crossover was fairly high, which complicates noninferiority interpretation: MTX arm: some switched to prednisone for adverse events and others had prednisone added for disease progression/persistent symptoms. Prednisone arm: some had MTX added. In noninferiority trials, heavy crossover can bias intention-to-treat analyses toward finding “no difference” (making noninferiority easier to claim). Per-protocol analyses avoid some of that but introduce other biases. They reported both. Safety signals (what to remember clinically) Adverse events were very common in both arms (almost everyone), mostly mild. Side-effect patterns fit expectations: Prednisone: more insomnia (and classic steroid issues). MTX: more headache/cough/rash, and notably liver enzyme elevations (about 1 in 4), with a small number discontinuing. Serious adverse events were rare; numbers were too small to confidently separate “signal vs noise,” but overall known risk profiles apply. Limitations (why you shouldn't over-read it) Open-label design, and FVC—while objective-ish—is still effort-dependent and can be influenced by expectation/behavior. Small trial, limiting subgroup conclusions (e.g., severity strata, different phenotypes). Generalizability issues (Netherlands demographics; US populations have higher rates of obesity/metabolic syndrome, which may tilt the steroid risk-benefit equation). Crossover reduces precision and interpretability of between-group differences over time. Practice implications (the “so what”) For many patients with pulmonary sarcoidosis needing systemic therapy, MTX is a reasonable initial alternative to prednisone when thinking long-term tolerability and steroid avoidance. Prednisone likely provides faster symptom/QoL relief in the first weeks—so it may be preferable when rapid improvement is important. The trial strengthens the case for a patient-centered discussion: short-term relief vs side-effect tradeoffs, and the possibility of early combination therapy in more severe cases (suggested, not proven).

While we celebrate the remarkable achievement of 250 years of the US military being a bulwark of democracy, it is important to understand the intentionally laid foundations on which America's civil military relations tradition rests. Military deference to civilian authority and the legislature is a principle pioneered and championed by General George Washington, setting a powerful precedent for commanding officers to follow… with some instructive exceptions. As we look toward the New Year, and wearily at the political posturing of some military leaders, Kori Schake reminds us of a central theme from her new book, The State and the Soldier (Polity, 2025): “We want a military that's not partisan. We want a military that is subordinate to whatever lunatics the American public see fit to put into high office.” How are military leaders inherently political? How do we avoid forcing them to make partisan choices? And, as we have discussed all year, why does Congress refuse to exercise the powers it has, even in this realm?Kori Schake is a senior fellow and the Director of Foreign and Defense Policy studies at the American Enterprise Institute. Before joining AEI, Dr. Schake was the deputy director-general of the International Institute for Strategic Studies in London. She has had a distinguished career in government, working at the US State Department, the US Department of Defense, and the National Security Council at the White House. She was also senior policy advisor on the 2008 McCain campaign. She has taught at Stanford, West Point, Johns Hopkins, and the University of Maryland. Dr. Schake is the author of 5 books, with her newest titled “The State and the Soldier: A History of Civil-Military Relations in the United States.”Read the transcript here.Subscribe to our Substack here.Find The State and the Soldier here.

One of the two semifinals was a classic, fit for kids from 1 to 92 ... if you can handle stress, that is.  And we aren't just spouting cliches when we say this is as good as it gets -- in the history of the national semifinals since automatic bids were added and the playoffs expanded beyond four rounds in 1999, there have been only two years where both semifinals were close. It's far more likely that both of them are two-score games! So to get not just one good one, but one epic one, well, that's great. When Kaleb Blaha threaded the tiniest hole to find Blake Rohrer, and Rohrer ran untouched to the end zone for a 79-yard touchdown against Johns Hopkins, it not only sent the Falcons to the Stagg Bowl for the first time ever, it united a community, and was another memorable moment in a friendship between the two. They talk about it, how they met, how Blaha recruited Rohrer to come out for the UW-River Falls football team, and how the River Falls community reacted on Saturday night, in Around the Nation. 2016 Around the Nation column: Out of darkness, light, by Adam Turer, featuring the rebuilding UW-River Falls program At North Central, the Cardinals got the best passing performance of the season from Garet Wilson, and Jack Rummell had some amazing catches and runs. What did Wilson say to him before a third-and-8 play, and how did Rummell respond? We also hear from transfer defensive end Eli Renick, and chat with coach Brad Spencer about what's next for North Central as they head to their sixth consecutive Stagg Bowl. Plus, for Johns Hopkins, what does this run ending mean for the state of the program? And for John Carroll, it's the end of two years where Nick Semptimphelter was able to play football for the Blue Streaks with tight end Terrence Rawls, who was not just his high school teammate, but a literal member of his family. He talks about that, and coach Jeff Behrman talks about Semptimphelter. Patrick and Greg also hand out game balls and we take your questions in the mailbag. That and more in this edition of the D3football.com Around the Nation podcast. The D3football.com Around the Nation podcast is a weekly conversation about NCAA Division III football, and has been running since 2007.

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Shai Rozen, MD, discuss the following articles from the January 2026 issue:   "The Efficacy of Flap Debulking after Facial Reanimation Surgery to Enhance Facial Symmetry" by Weiss, Fricke, Hohenstein, et al.   "The Natural Progression of Synkinesis" by Rail, Bhatia, Dragun, et al.   "Extended Sural Nerve Harvest: A Technique to Gain Additional Graft Length" by Millesi, Gates-Tanzer, Felzen, et al.   Special guest, Shai Rozen is Professor and Vice-Chairman in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center and Director of the Facial Reanimation Program, specializing in treating patients with facial paralysis. He completed both general surgery and plastic surgery training at Johns Hopkins, followed by fellowships in both craniofacial and peripheral nerve surgery.    READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJan26Collection   The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

A new test may identify ALS up to a decade before symptoms appear, research by Alex Pantelyat, a movement disorders expert at Johns Hopkins, and colleagues has shown. Pantelyat says there are certain groups of people who may benefit from … Can a new test help those at risk to develop ALS? Elizabeth Tracey reports Read More »

A smartphone app helped people with prediabetes improve their lifestyles as much as a human led diabetes prevention program, research from Nas Mathioudakis, a diabetes expert at Johns Hopkins, and colleagues has shown. Mathioudakis says future plans to let the … How do we ensure safety with medical apps? Elizabeth Tracey reports Read More »

Testing hundreds of blood samples collected years ago allowed researchers at Johns Hopkins and elsewhere to create a panel of proteins that point to the develop of ALS, or Lou Gehrig's disease, up to 10 years later. Alex Pantelyat, a … Looking retrospectively at blood samples allows researchers to spot ALS, Elizabeth Tracey reports Read More »

In his weekly clinical update, Dr. Griffin and Vincent Racaniello protest Vinjay Prasad, head of CBER FDA Nov memo stating administration of the COVID-19 vaccine resulted in 10 children's deaths, but are cautiously delighted by the December memo from those in CBER who dispute this data-less claim, how in 31 states pertussis vaccination rates have declined before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, of clinical outcomes of oseltamivir versus baloxavir for treating influenza infection, number deaths associated with COVID-19 hospitalizations and disease associated economic burden, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how the German government is committed to research into long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Industry laments Prasad vaccine memo (Politico) Scoop: FDA vaccine chief's memo cited 10 pediatric Covid-19 vaccine deaths—but the agency's own analysis found 0–7 (Inside Medicine) Whooping cough cases soar as vaccination rates drop (NBC News) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Comparison of clinical outcomes of oseltamivir versus baloxavir in outpatients with influenza: a retrospective cohort analysis (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (CDC:MMWR) Mortality following recovery from COVID-19 hospitalization: A long-term cohort study (International Journal of Infectious Diseases) COVID hospitalization tied to 69% higher risk of death for up to 2 years (CIDRAP) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir (Journal of Medical Economics) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments?(Nature) Reaching out to US house representative Letters read on TWiV 1280 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Send us a textWhat if the most powerful tool on a crisis scene isn't a badge or a diagnosis, but a practiced partnership? We continue our conversation with Dr. Sarah Abbott about co-response and unpack how pairing clinicians with police changes the outcome of calls involving mental health, substance use, and high-stress events—from domestic incidents with kids present to house fires and welfare checks where information is thin.We trace the arc from a pioneering certificate at William James College to statewide intensives built on scenario-based, hands-on training. Instead of chasing labels, the curriculum teaches behavior reading, de-escalation under pressure, and language that preserves dignity while lowering risk. We dig into veterans' mental health and firearm culture, highlighting lethal means safety training that helps clinicians speak credibly about storage, temporary transfer, and time-limited access without shaming or seizing. A vivid field story shows how clear communication with dispatch and officers can soften the room, protect everyone on scene, and build trust that lasts past one call.The conversation widens to where co-response goes next. Through Abbott Solutions for Justice and the International Co-Responder Alliance, these practices are spreading across states and overseas, with growing momentum on college campuses that function like small cities. We explore why campus police and clinicians need shared playbooks, how programs like Johns Hopkins are leading, and what it takes to turn skepticism into skill—consistently, respectfully, and at scale. If you care about first responder wellness, community safety, and practical tools that work at 2 a.m., this is your roadmap for doing crisis response better.Subscribe for more conversations on co-response, first responder mental health, and practical de-escalation. Share this episode with a colleague who needs these tools, and leave a quick review to help others find the show.To reach Sarah, please visit her website at: https://www.abbottsolutionsforjustice.comSarah can also befound on LinkedIn at: https://www.linkedin.com/company/abbott-solutions-for-justice-llc/?viewAsMember=trueFreed.ai: We'll Do Your SOAP Notes!Freed AI converts conversations into SOAP note.Use code Steve50 for $50 off the 1st month!Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showYouTube Channel For The Podcast

Food as Medicine: Dr. Elizabeth Klodas – Disrupting Cardiology with Clinical Nutrition Join us as we explore a critical question: What if the solution to America's number one killer isn't in the pharmacy, but in the kitchen? Today's guest is Dr. Elizabeth Klodas, a Mayo Clinic and Johns Hopkins-trained cardiologist who founded Step One Foods after realizing that doctors, including herself, weren't addressing the most powerful intervention for heart disease diet. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

#5 ranked Johns Hopkins WBB head coach, Rodney Rogan joins this week's episode of @Notevend2 . JHU looks like one of the best teams in the country holding a perfect 8-0 record. In just two years, Rogan and JHU have now won back-to-back Centennial Conference Championships and made multiple Sweet 16 appearences. Rogan has now won at two different schools- beginning at his first head coaching opportunity at Rhodes College. Rogan led Rhodes to three straight Southern Atlantic Athletic (SAA) championships leaving with a 67-28 (.705) record. This pod talks about his process of getting to JHU, what the expectations are for the 2025-26 season, and the background of Rogan getting into coaching women's basketball. This episode is available wherever you get your podcasts. Follow/subscribe to @Notevend2 for more sports content! Enjoy the episode ...

Most practices are busy—but busy doesn't always mean profitable. In this episode of Sharkpreneur, Seth Greene interviews Terri Ross, Founder of Terri Ross Consulting & Co-Founder of Aesthetic Success, who is one of the leading voices in the medical aesthetics industry. With nearly two decades of experience, she has advised top practices, trained thousands of providers, and been featured as a speaker at Johns Hopkins, international conferences, and in multiple publications. In this conversation, Terri shares her proven seven-pillar revenue optimization system, insights on KPIs that drive millions in growth, and strategies to help practices thrive in competitive markets. Key Takeaways: → Why being busy doesn't guarantee profitability. → The seven-pillar framework for revenue optimization. → Common mistakes most practice owners make—and how to avoid them. → The KPIs that matter most in the first 3–6 months. → How pricing and compensation strategies impact profitability. Terri Ross, founder of Terri Ross Consulting, is a globally recognized expert in practice management and high-performance sales coaching, with a specialization in medical aesthetics. She has helped practices and Fortune 500 companies achieve over $2.5M in annual revenue growth. Industry leaders like Galderma, Skinbetter, and Merz Canada rely on her expertise for training sales teams and delivering keynote presentations at top aesthetic conferences. As the founder of Terri Ross Consulting, she later launched the APX Platform, merging with a patient education firm in 2023 to form a cutting-edge performance system. With a background in sales leadership roles with Fortune 500 medical device companies, Terri consistently ranked in the top 10% nationally. Terri hosts the "In Touch with Terri" podcast and co-founded Aesthetic Success, a quarterly summit series designed to master business strategy in aesthetics. Connect With Terri Ross: Website: https://terrirossconsulting.com/ Instagram: https://www.instagram.com/terrirossconsulting/ LinkedIn: https://www.linkedin.com/in/terriross/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Most practices are busy—but busy doesn't always mean profitable. In this episode of Sharkpreneur, Seth Greene interviews Terri Ross, Founder of Terri Ross Consulting & Co-Founder of Aesthetic Success, who is one of the leading voices in the medical aesthetics industry. With nearly two decades of experience, she has advised top practices, trained thousands of providers, and been featured as a speaker at Johns Hopkins, international conferences, and in multiple publications. In this conversation, Terri shares her proven seven-pillar revenue optimization system, insights on KPIs that drive millions in growth, and strategies to help practices thrive in competitive markets. Key Takeaways: → Why being busy doesn't guarantee profitability. → The seven-pillar framework for revenue optimization. → Common mistakes most practice owners make—and how to avoid them. → The KPIs that matter most in the first 3–6 months. → How pricing and compensation strategies impact profitability. Terri Ross, founder of Terri Ross Consulting, is a globally recognized expert in practice management and high-performance sales coaching, with a specialization in medical aesthetics. She has helped practices and Fortune 500 companies achieve over $2.5M in annual revenue growth. Industry leaders like Galderma, Skinbetter, and Merz Canada rely on her expertise for training sales teams and delivering keynote presentations at top aesthetic conferences. As the founder of Terri Ross Consulting, she later launched the APX Platform, merging with a patient education firm in 2023 to form a cutting-edge performance system. With a background in sales leadership roles with Fortune 500 medical device companies, Terri consistently ranked in the top 10% nationally. Terri hosts the "In Touch with Terri" podcast and co-founded Aesthetic Success, a quarterly summit series designed to master business strategy in aesthetics. Connect With Terri Ross: Website: https://terrirossconsulting.com/ Instagram: https://www.instagram.com/terrirossconsulting/ LinkedIn: https://www.linkedin.com/in/terriross/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode Bill interviews Dr. John Gartner, a former Johns Hopkins professor and founder of Duty to Warn. In his return to the Bill Press Pod, Dr. Gartner provides an in-depth analysis of President Donald Trump's cognitive health, asserting that Trump exhibits signs of severe cognitive decline and personality disorders such as malignant narcissism. He discusses specific instances that showcase Trump's deteriorating mental state, including erratic behavior, memory lapses, and lack of empathy. The episode delves into the challenges and dangers posed by Trump's mental condition, its implications on his presidency, and potential future scenarios.Today Bill once again highlights the work of Chef Jose Andres' World Central Kitchen. While the Trump administration is decimating America's soft power around the world, and our role as a provider of aid to people and countries in peril, the World Central Kitchen goes where they're needed. No matter the war zone nor the danger of a natural disaster. This is one of Carol and my favorite charities and I hope you'll support them at WCK.orgSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

George Kikvadze is the Founder of Cryptic8 VC, investing at the intersection of technology and longevity. He is also Vice Chairman and an early backer of Bitfury Group, the company at the heart of this book. A Bitcoin pioneer since 2013, he was privileged to be behind three tech unicorns - Bitfury, Cipher Mining, and Hut 8 - with a combined value exceeding $12 billion. A graduate of Wharton and Johns Hopkins, George enjoys tennis, chess, and raising his two sons. Bill Tai has funded startups since 1991, with 23 becoming publicly listed companies. An early backer of Zoom, Canva, and Dapper Labs, he also co-founded data pioneer Treasure Data (acquired by SOFTBANK) and IPInfusion (TSE:4813). Originally a chip designer at LSI Logic and Taiwan Semiconductor, he later led semiconductor IPOs at Alex Brown & Sons. He holds a BSEE from the University of Illinois and an MBA from Harvard, where he advises the Dean. He chairs ACTAI Global, uniting entrepreneurs and innovators for tech-based conservation. Learn about the inside story of Bitcoin in this great new book, And Then You Win: A Start-Up's Untold Story of Grit, Grind, and Glory Anthony Scaramucci is the founder and managing partner of SkyBridge, a global alternative investment firm, and founder and chairman of SALT, a global thought leadership forum and venture studio. He is the host of the podcast Open Book with Anthony Scaramucci. A graduate of Tufts University and Harvard Law School, he lives in Manhasset, Long Island.

From college dorms to quiet suburbs, fentanyl's reach no longer fits a stereotype. This week on Pathology with Dr. Priya, a Zone 7 series, Sheryl McCollum and Dr. Priya Banerjee confront the reality of a Providence College house party that nearly claimed seven young lives. Together they discussed the chemistry, economics, and criminal psychology behind modern synthetic drugs, showing how a single white powder can conceal a fatal mix, and how dealers prioritize profit over safety. These drugs do not discriminate; they affect every community, every family, and every socioeconomic group. For parents, this episode serves as a reminder that prevention begins long before a crisis. Awareness, honest conversation, and early education remain the most powerful safeguards against tragedy. Highlights • (0:00) Welcome to Zone 7’s Pathology with Dr. Priya: “’Tis the season”: why overdoses spike between Thanksgiving and New Year’s • (0:45) Seven Providence College students found unresponsive at a house party • (3:00) Fentanyl's evolution from heroin corridors to every college town in America • (5:00) Cutting agents and chemical roulette: what's really in the “white powder” • (7:00) Xylazine, ketamine, and the rise of “zombie drugs” and clandestine labs • (11:15) Dealers, profit, and the deadly absence of quality control • (12:30) "Drugs don't discriminate": how overdose affects every class and community • (16:30) As holiday parties ramp up, Sheryl and Dr. Priya address alcohol, impaired driving, and false confidence behind the wheel• (18:15) “There ain’t a drug dealer out there that cares about anybody they’ve ever sold to”: how profit drives addiction across every demographic • (22:15) Final reflections: stay aware, stay connected, and keep the season focused on life, not loss About the Hosts Dr. Priya Banerjee is a board-certified forensic pathologist with extensive experience in death investigation, clinical forensics, and courtroom testimony. A graduate of Johns Hopkins, she served for over a decade as Rhode Island’s state medical examiner and now runs a private forensic pathology practice. Her work includes military deaths, and high-profile investigations. Dr. Priya has also been featured as a forensic expert on platforms such as CrimeOnline and Crime Stories with Nancy Grace. She is a dedicated educator, animal lover, and proud mom. Website: anchorforensicpathology.com Twitter/X: @Autopsy_MD Sheryl “Mac” McCollum is an active crime scene investigator for a Metro Atlanta Police Department and the director of the Cold Case Investigative Research Institute, which partners with colleges and universities nationwide. With more than 4 decades of experience, she has worked on thousands of cold cases using her investigative system, The Last 24/361, which integrates evidence, media, and advanced forensic testing. Her work on high-profile cases, including The Boston Strangler, Natalie Holloway, Tupac Shakur and the Moore’s Ford Bridge lynching, led to her Emmy Award for CSI: Atlanta and induction into the National Law Enforcement Hall of Fame in 2023. Email: coldcase2004@gmail.com Twitter/X: @ColdCaseTips Facebook: @sheryl.mccollum Instagram: @officialzone7podcast

It's a milestone podcast, but we're not quite to the final stage of the Division III football season. You can't blame us for getting dressed up -- OK, maybe just Greg decided to dress up for the audio podcast. But answering the call to the Final Four ball were who most people thought they were in our predictions this week: Johns Hopkins, John Carroll, North Central and UW-River Falls. And instead of doing the blow-by-blow of each game -- because, let's be honest, the average margin of victory was nearly 20 points -- let's hear from people in the middle of each of these games. So we'll be joined by John Carroll cornerback Dylan Crasi, who spent the first half on the sidelines but made his presence known right away in the third quarter. We'll talk to North Central quarterback Garet Wilson, whose first year in Division III since coming from Oklahoma State has been a revelation for both Division III and for him. We chat with UW-River Falls coach Matt Walker about the schematic and playbook choices the Falcons made this week, how they kept players warm (seriously, there was a detailed plan). And Keith McMillan talks to Johns Hopkins offensive lineman Michael Nwosu and defensive lineman Graham Hodge about their play on a day where the Blue Jays' line play was huge. Plus, the coaching carousel continues to turn as Ithaca loses a second consecutive coach to the Ivy League. Sewanee makes a hire who has much more D-III experience than the last guy they hired. And Lawrence didn't even give its new coach six months before cutting him loose?  Patrick and Greg also hand out game balls and we take your questions in the mailbag segment, and Patrick gives an early Stagg Bowl prediction? That and more in this edition of the D3football.com Around the Nation podcast.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss the rise in norovirus infections, contamination of infant formula and botulism outbreak, confusion and response to the CDC's ACIP decision to reverse the recommendation for a birth dose of the hepatis B virus vaccine and how states in the Northwest and Northeast are responding as well as some insurance companies, then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, South Carolina's imposed quarantine of individuals due to their accelerated measles outbreak, neurotropism of H1N1, benefits of the RSV and COVID vaccines, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Norovirus season! (Wastewater Scan) Outbreak Investigation of Infant Botulism: Infant Formula (November 2025) (FDA: Foodborne illnesses) Botulism outbreak sickens more than 50 babies and expands to all ByHeart products (AP News) CDC advisers drop decades-old universal hepatitis B birth dose recommendation, suggest blood testing after 1 dose (CIDRAP) Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023 (CDC: MMWR) Universal Hepatitis B vaccination at birth: safety, effectiveness and public health impact (CIDRAP) Recommended Child and Adolescent Immunization Schedule for Ages 18 years or younger (American Academy of Pediatrics) West Coast health experts reject RFK Jr. panel, say hepatitis B vaccines at birth should continue (The Oregonian) Statement from the Northeast Public Health Collaborative In Response to ACIP's Hepatitis B Vote (NJ.Gov Health) Governors Denounce ACIP Recommendation on Hepatitis B Vaccination, Reaffirm Commitment to Strong, Evidence-Based Childhood Vaccination Programs (Governors Public Health Alliance) Blue Cross and Blue Shield Companies Statement on Vaccines (Blue Cross Blue Shield) AHIPStatement on Vaccine Coverage (AHIP) Pediatricians reject CDC advisers' guidance, plan to continue vaccinating all newborns against hepatitis B (CIDRAP) Survey: Social media on par with CDC as trusted vaccine source (Healio) FDA to investigate whether adult deaths linked to COVID vaccine (Washington Post) Exclusive: US FDA launches fresh safety scrutiny of approved RSV therapies for infants (Reuters) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Contemporary highly pathogenic avian influenza (H5N1) viruses retain neurotropism in human cerebral organoids (OFID) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Indiana, cases of New World screwworm in Mexico, rising US flu activity (CIDRAP) Mexico reports 92 cases of myiasis in humans caused by screwworm (Expreso.press) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Types of Influenza Viruses (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Intensive Care Unit Stay and Mechanical Ventilation Among Adults with Respiratory Syncytial Virus-Related Hospitalization by Age and Comorbidity Status (Infectious Diseases and Therapy) Cardiovascular Events 1 Year After Respiratory Syncytial Virus Infection in Adults (JAMA: Open Network) Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022–September 2023 (CDC: Emerging Infectious Diseases) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis (LANCET: Infectious Diseases) Effectiveness of Nirsevimab in Preventing Respiratory Syncytial Virus-related Burden: A Test-negative Case-control Study in Infants With Bronchiolitis in Lombardy Region, Italy (The Pediatric Infectious Disease Journal) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy (Obstetrics & Gynecology) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France (JAMA: Open Network) Two-year prognosis of mRNA vaccine-related myocarditis compared with historical conventional myocarditis: a population-based cohort study (CMI: Clinical Microbiology and Infection) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1278 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

"It's recommended that everyone over the age of 40 go see their eye doctor once a year." -Dr. Rudrani Banik   Dr. Rudrani "Rani" Banik is a renowned board-certified neuro-ophthalmologist and an integrative medicine specialist based in New York City. She holds the position of Associate Professor of Ophthalmology at Mount Sinai and has an impressive educational background, including an MD from Brown University, a residency at UC Irvine, and a fellowship at the Wilmer Eye Institute at Johns Hopkins. Dr. Banik adopts a holistic approach to eye health, focusing on nutrition, lifestyle, and supplementation. She is also a prolific author and media expert, featured on platforms like Good Morning America, NBC, and The New York Times. Episode Summary: Join host Jana Short in an engaging conversation with Dr. Rudrani "Rani" Banik, renowned neuro-ophthalmologist and integrative medicine specialist, as they delve into the intricacies of eye health and holistic wellness. In this enlightening episode, Dr. Banik shares her personal journey with chronic daily migraines, which led her to discover the powerful potential of lifestyle and dietary changes in managing health conditions. With a foundation in conventional medicine, she transitioned to a more integrative approach, emphasizing the importance of diet, stress management, and functional medicine in overall well-being.   Throughout the episode, Dr. Banik discusses her innovative work in eye health, emphasizing the role of nutrition and supplements in maintaining optimal vision. She elaborates on the extensive array of nutrients, beyond the well-known carrots, that contribute to eye health, such as lutein and zeaxanthin. Her insights extend to the necessity of regular eye examinations and lifestyle adjustments to protect and preserve ocular health. Dr. Banik also introduces her supplement line, Ageless by Dr. Rani, and her book, "Beyond Carrots," showcasing her dedication to educating others on the significance of holistic eye care.   Key Takeaways: Dr. Rani Banik's journey with chronic migraines led her to embrace integrative medicine, highlighting the impact of diet and lifestyle on health management. Regular eye checkups are crucial, as the eyes can reveal early signs of over 200 medical conditions. Beyond carrots, nutrients like lutein, zeaxanthin, and meso-zeaxanthin are vital for eye health, acting as internal sunglasses and blue blockers. Incorporating diverse foods, such as leafy greens, bell peppers, and spices, can significantly reduce the risk of eye diseases. Supplements should complement a healthy diet, filling in nutritional gaps due to factors like dietary absorption or soil nutrient depletion.   Resources: www.drranibanik.com https://www.facebook.com/rudrani.banik.2025/ @‌dr.ranibanik https://x.com/RudraniBanikMD     ✨ Enjoying the show? Stay inspired long after the episode ends! Jana is gifting you **free subscriptions to Ageless Living Magazine and **Best Holistic Life Magazine—two of the fastest-growing publications dedicated to holistic health, personal growth, and living your most vibrant life. Inside, you'll find powerful stories, expert insights, and practical tools to help you thrive—mind, body, and soul.  

The Rich Zeoli Show- Hour 4: 6:00pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 6:30pm-While speaking with New York Post reporter Miranda Devine, FDA Director and Johns Hopkins surgeon Dr. Marty Makary documented the ways former Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci was involved in a massive attempt to suppress the truth about Covid-19's origins. 6:40pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams.

The Rich Zeoli Show- Full Show (12/03/2025): 3:05pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 3:10pm- While speaking with the press on Tuesday, President Donald Trump called for a reduction of migrants from third world countries who are openly unwilling to assimilate to American culture. 3:20pm- Philadelphia Highway Patrol Officer Andy Chan has died six years after he was struck by a vehicle while on duty. Rich notes that Officer Chan was a friend of the show. Next Friday the show will be broadcasting from the 6th Annual Andy Chan Holiday Block Party. 3:30pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. 4:05pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 4:40pm- Carrie Severino—President of the Judicial Crisis Network (JCN) & Co-Author of the book, “Justice on Trial: The Kavanaugh Confirmation and the Future of the Supreme Court.”—joins The Rich Zeoli Show. On Tuesday, the U.S. Supreme Court heard oral argument in First Choice Women's Resource Centers v. Platkin. The case asks whether a federal court can hear First Choice's First Amendment challenge to a New Jersey investigatory subpoena when no state court has yet ordered the group to comply. While being questioned by Justice Clarence Thomas, NJ Attorney General Sundeep Iyer conceded that NJ hasn't received any public complaints to justify its subpoena against the pro-life health center. 5:05pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. The New York Times, as well as the White House, dispute that Hegseth explicitly authorized the second strike or ordered to eliminate survivors. The NYT also reports that the “U.S. military intercepted radio communications from one of the survivors to what [officials] said were narco-traffickers.” 5:30pm- Following the Eagles loss to the Bears on Friday, Offensive Coordinator Kevin Patullo had his house egged. Does Justin have an alibi? Plus, a drunk racoon ransacked a convenience store! And “Be Nice to Matt Week” continues…sort of… 6:00pm- Speaking from the Oval Office, President Trump, alongside Transportation Secretary Sean Duffy, announced a repeal of onerous fuel efficiency regulations put in place under the Biden administration. They had been designed to artificially boost electric vehicle manufacturing and sales. Trump described the policy shift as a win for consumers—as the previous efficiency standards led to higher prices on new vehicles. 6:30pm-While speaking with New York Post reporter Miranda Devine, FDA Director and Johns Hopkins surgeon Dr. Marty Makary documented the ways former Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci was involved in a ma ...

The Rich Zeoli Show- Hour 4: 6:00pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. 6:20pm- Food and Drug Administration (FDA) Commissioner, and Johns Hopkins surgeon, Dr. Marty Makary weighed in on a theory that Lyme disease may have originated from a bioweapons laboratory. 6:40pm- In her latest editorial for The New York Post, Miranda Devine writes that a “damning report” labels the Federal Bureau of Investigation (FBI) as a “rudderless ship” and “all f*cked up” under the leadership of Director Kash Patel and Deputy Director Dan Bongino. The report alleges that Bongino has an “unfortunate obsession with social media.”

The Rich Zeoli Show- Full Episode (12/01/2025): 3:05pm- The man allegedly responsible for shooting two National Guard members had been granted asylum from Afghanistan. While on Meet the Press, Department of Homeland Security Secretary Krisit Noem said initial investigations suggest the man became radicalized while in the United States. 3:10pm- In her latest editorial for The New York Post, Miranda Devine writes that a “damning report” labels the Federal Bureau of Investigation (FBI) as a “rudderless ship” and “all f*cked up” under the leadership of Director Kash Patel and Deputy Director Dan Bongino. The report alleges that Bongino has an “unfortunate obsession with social media.” 3:30pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 3:50pm- It's finally here! “Be Nice to Matt DeSantis Week” kicks off. Earlier this year, Linda Kerns—Attorney & Pennsylvania Election Integrity Counsel for the Republican National Committee and Donald Trump—donated money to the Travis Manion Foundation during 1210 WPHT's fundraiser in exchange for Rich guaranteeing he would be nice to Matt for one full week before the end of the year. 4:05pm- A report from Ernesto Londono of The New York Times documents rampant fraud plaguing Minnesota—dozens of people have been charged with stealing more than $1 billion in taxpayer money from programs meant to feed hungry children and provide therapy for autistic children. Critics of Governor Tim Walz say his administration allowed the fraud to persist “partly because state officials were fearful of alienating the Somali community” who were largely responsible for the scams. 4:15pm- Is even Europe getting sick of far-left taxation policies? On Sunday, Switzerland rejected a referendum that would have placed a 50% inheritance tax on assets above 50 million Swiss francs, or about $62 million. 4:40pm- TV recommendations: Death by Lightning on Netflix—which is based on Candece Millard's book on the assassination of President James Garfield. 5:05pm- The man allegedly responsible for shooting two National Guard members had been granted asylum from Afghanistan. While on Meet the Press, Department of Homeland Security Secretary Krisit Noem said initial investigations suggest the man became radicalized while in the United States. National Guard member Sarah Beckstorm, sadly, died from her wounds. Meanwhile, Guardsman Andrew Wolfe remains in critical condition. West Virginia Gov. Patrick Morrisey said Wolfe was responsive on Monday. 5:25pm- Last month, while speaking from the House floor, Rep. Jasmine Crockett (D-TX) accused several Republicans including EPA Administrator Lee Zeldin of taking campaign donations from Jeffrey Epstein. However, her claim was horribly misleading. The donations were from a Dr. Jeffrey Epstein—a different Jeffery Epstein, with no relation to the predator. Astoundingly, Crockett recently doubled down on her outlandish claims during a segment on MS Now. 5:40pm- Linda Kerns calls in to outline the rules for “Be Nice to Matt Week”—so far, Rich has violated every instruction. 6:00pm- A Washington Post report states that Department of War Secretary Pete Hegseth authorized a series of deadly strikes on a drug trafficking boat in the Caribbean, ordering military officials to “kill everybody.” The directive, according to the report, led to a second strike killing several crew members that survived the initial assault on the vessel. 6:20pm- Food and Drug Administration (FDA) Commissioner, and Johns Hopkins surgeon, Dr. Marty Makary weighed in on a theory that ...